Exploring food and medicine homology: potential implications for cancer treatment innovations
Mengyao Li,
No information about this author
Ao Gu,
No information about this author
Jiatong Li
No information about this author
et al.
Acta Materia Medica,
Journal Year:
2025,
Volume and Issue:
4(2)
Published: Jan. 1, 2025
The
concept
of
food
and
medicine
homology
(FMH)
is
deeply
embedded
in
traditional
Chinese
carries
historical
importance.
recent
rigorous
definition
FMH
pertains
to
substances
that
exhibit
both
pharmacological
nutritional
functions,
have
active
ingredients
are
fundamentally
non-toxic
appropriate
for
extended
consumption.
With
the
progression
modern
biotechnology,
application
this
treating
diseases
has
markedly
expanded,
its
intrinsic
mechanisms
been
examined
detail.
use
cancer
therapy,
as
either
a
primary
treatment
or
an
adjuvant
paved
way
low-toxicity
treatments.
This
commentary
examines
theoretical
underpinnings,
potential
advantages,
practical
applications
prevention,
treatment,
support
enhancement.
Advantages
including
low
toxicity,
long-term
edibility,
minimal
adverse
effects,
high
patient
compliance
discussed.
Moreover,
owing
multicomponent
multitarget
characteristics,
may
provide
novel
opportunities
therapy.
Given
lethality
associated
ethical
implications,
current
research
should
prioritize
fundamental
studies
investigating
Concurrently,
preliminary
preclinical
would
be
establish
solid
foundation
subsequent
clinical
trials.
Language: Английский
Cross-Talk Between Tumor Cells and Stellate Cells Promotes Oncolytic VSV Activity in Intrahepatic Cholangiocarcinoma
Cancers,
Journal Year:
2025,
Volume and Issue:
17(3), P. 514 - 514
Published: Feb. 4, 2025
As
the
mechanisms
underlying
tumorigenesis
become
better
understood,
dynamic
roles
of
cellular
components
tumor
microenvironment,
and
their
cross-talk
with
cells,
have
come
to
light
as
key
drivers
disease
progression
emerged
important
targets
new
cancer
therapies.
In
field
oncolytic
virus
(OV)
therapy,
stromal
cells
been
considered
potential
barriers
viral
spread,
thus
limiting
replication
therapeutic
outcome.
However,
evidence
indicates
that
intratumoral
fibroblasts
could
support
replication.
We
demonstrated
in
a
rat
model
stromal-rich
intrahepatic
cholangiocarcinoma
(CCA)
vesicular
stomatitis
(VSV)
can
be
localized
within
hepatic
stellate
(HSCs),
addition
when
was
applied
via
arterial
infusion.
Furthermore,
VSV
shown
efficiently
kill
CCA
activated
HSCs,
co-culture
HSCs
increased
titers.
Interestingly,
this
effect
is
also
observed
each
cell
type
cultured
alone
conditioned
medium
other
type,
indicating
secreted
factors
are
at
least
partially
responsible
for
phenomenon.
Partial
reduction
sensitivity
I
interferons
systems,
providing
possible
mechanism
Together,
results
indicate
targeting
provide
an
additional
OV
which,
until
now
has
not
considered.
these
findings
suggest
potentially
powerful
agent
tumors,
such
pancreatic
cancer,
both
which
very
difficult
treat
conventional
therapy
poor
prognosis.
Language: Английский
Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases
Cancers,
Journal Year:
2025,
Volume and Issue:
17(6), P. 1048 - 1048
Published: March 20, 2025
Background:
This
study
aimed
to
assess
the
safety
and
efficacy
of
gemcitabine
plus
S-1-based
chemoradiotherapy
(GS-CRT)
among
patients
with
locally
advanced
pancreatic
ductal
adenocarcinoma
(PDAC),
especially
those
unresectable
(UR-LA)
cases.
Methods:
A
total
351
consecutive
PDAC
were
enrolled
prognostic
predictors
disease-specific
survival
(DSS)
identified.
Results:
The
treatment
completion
rate
was
98.9%
Grade
3
or
higher
adverse
events
occurred
in
181
cases
(51.6%).
Among
319
re-evaluated
patients,
pancreatectomy
performed
184
(57.7%).
Based
on
resectability,
5-year
DSS
rates
for
entire
cohort
39.6%
(R),
43.8%
(BR-PV),
21.2%
(BR-A)
13.3%
(UR-LA),
while
performance
status
(PS),
hemoglobin
(Hb)
level,
celiac
artery
(CA)
involvement
≥180
degrees
JPS
8th
T
category.
In
resected
cases,
preoperative
PS,
CA19-9
JPS-T
factor,
degree
histological
response
adjuvant
chemotherapy.
UR-LA
nutritional
index
(PNI),
absence
pathological
venous
invasion
chemotherapy
DSS.
Conclusions:
Even
though
encountered
about
half
they
uneventfully
managed.
Therefore,
GS-CRT
is
safe
highly
tolerable
potential
improve
patients‘
prognosis.
Preoperative
levels
are
important
factors,
as
well
therapy.
(PNI)
curative
intent
surgery.
Language: Английский
Inducing Targeted, Caspase-Independent Apoptosis with New Chimeric Proteins for Treatment of Solid Cancers
Orly Melloul,
No information about this author
Samar Zabit,
No information about this author
Michal Lichtenstein
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1179 - 1179
Published: March 31, 2025
Background:
Most
newly
developed
anticancer
treatments
trigger
tumor
cell
death
through
apoptosis,
for
which
involvement
of
caspases
activity
is
essential.
However,
numerous
mutations
in
apoptotic
pathways
that
lead
to
cancer
and
favor
resistance
apoptosis
are
known;
most
related
caspase-dependent
thus
have
low
efficacy.
To
overcome
these
limitations,
we
constructed
a
novel
chimeric
protein,
GnRH-AIF,
using
gonadotropin-releasing
hormone
(GnRH)
analog
as
targeting
moiety
the
apoptosis-inducing
factor
(AIF)
its
cleaved
form
killing
moiety,
fused
at
cDNA
level.
AIF
has
crucial
role
caspase-independent
pathway.
A
wide
variety
solid
tumors
overexpress
GnRH-receptors
(GnRH-R)
targeted
by
new
GnRH-AIF
protein.
Methods
Results:
In
this
study,
constructed,
expressed,
highly
purified
proteins.
We
demonstrated
ability
chimera
enter
specifically
very
efficiently
kill
lines
overexpressing
GnRH-R.
importantly,
upon
entry,
GnRH-AIFs
translocate
nucleus
where
it
causes
DNA
fragmentation
leading
direct
death.
As
AIFs
lack
nuclease
activity,
our
findings
also
emphasize
induced
dependent
on
presence
ENDOG
PPIA
proteins,
known
participate
formation
DNA-degradosome
complex.
Finally,
high
anti-tumor
efficacy
ex
vivo,
human,
colon
organoid
model.
Conclusions:
Our
study
shows
potential
protein
approach
treat
cancers
GnRH-R,
via
Language: Английский
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas
Natalia Gorbokon,
No information about this author
Katharina Teljuk,
No information about this author
Viktor Reiswich
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1205 - 1205
Published: April 1, 2025
The
complete
loss
of
S-methyl-5'-thioadenosine
phosphorylase
(MTAP)
expression,
often
due
to
homozygous
9p21
deletion,
creates
a
druggable
vulnerability
in
cancer
cells.
A
total
769
primary
pancreatic
ductal
adenocarcinomas
were
analyzed
on
tissue
microarrays
with
MTAP
immunohistochemistry
(IHC)
and
fluorescence
situ
hybridization
(FISH).
Intratumoral
heterogeneity
was
assessed
"heterogeneity"
TMA
containing
up
nine
samples
from
different
areas
236
tumor
nodal
metastases,
whole
sections
all
blocks
19
cancers.
expression
found
181
(37.9%)
478
interpretable
tumors
unrelated
pT,
pN,
grade,
size.
homogenous
37.6%
heterogeneous
1.1%
the
tumors,
at
least
three
evaluable
TMA.
On
sections,
1
showed
loss.
correlation
between
IHC
FISH
nearly
perfect,
98.8%
MTAP-deficient
showing
deletion.
is
frequent,
caused
by
mostly
homogeneous
adenocarcinomas.
Considering
also
their
aggressive
clinical
behavior,
may
represent
an
ideal
type
for
studying
new
drugs
targeting
cells
trials.
Language: Английский